Effect of hepatic insufficiency on pharmacokinetics and drug dosing.
- 1 January 1998
- journal article
- review article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Pharmacy
- Vol. 20 (5), 183-192
- https://doi.org/10.1023/a:1008656930082
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Assessment of Liver Metabolic FunctionClinical Pharmacokinetics, 1994
- Extrahepatic Metabolism of Drugs in HumansClinical Pharmacokinetics, 1994
- Individual Variation in First-Pass MetabolismClinical Pharmacokinetics, 1993
- Identification of Patients with Impaired Hepatic Drug Metabolism Using a Limited Sampling Procedure for Estimation of Phenazone (Antipyrine) Pharmacokinetic ParametersClinical Pharmacokinetics, 1993
- P450 EnzymesClinical Pharmacokinetics, 1992
- Pharmacokinetics of Temafloxacin in Patients with Liver Impairment†Clinical Pharmacokinetics, 1992
- Clinical Pharmacokinetics in Patients with Liver DiseaseClinical Pharmacokinetics, 1991
- Clinical Significance of Pharmacokinetic Models of Hepatic EliminationClinical Pharmacokinetics, 1990
- First-Pass EliminationClinical Pharmacokinetics, 1984
- Hepatic First-pass Metabolism in Liver DiseaseClinical Pharmacokinetics, 1979